Sustained reprogramming of the estrogen response after chronic exposure to endocrine disruptors

Molecular Endocrinology

Volumn 29, Issue 3, 2015, Pages 384-395

  Patterson, Andrea R ^a,c   Mo, Xiaokui ^b   Shapiro, Ali ^a,c   Wernke, Karen E ^a   Archer, Trevor K ^d   Burd, Craig J ^a,c  

^a Department of Molecular Genetics ^*  (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DEOXYRIBONUCLEASE; ENDOCRINE DISRUPTOR; ESTROGEN; ESTROGEN RECEPTOR; GENISTEIN; TRANSCRIPTOME; EARLY GROWTH RESPONSE FACTOR 3; EGR3 PROTEIN, HUMAN; LIGAND;

ARTICLE; BREAST CANCER CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC EPIGENESIS; GENETICS; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; EARLY GROWTH RESPONSE PROTEIN 3; ENDOCRINE DISRUPTORS; EPIGENESIS, GENETIC; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; HUMANS; LIGANDS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 84923690291     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1237     Document Type: Article

References (37)

1. Dahlman-Wright K, Qiao Y, Jonsson P, Gustafsson JA, Williams C, Zhao C. Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells. Carcinogenesis. 2012;33:1684-1691.
2. Palanza P, Morellini F, Parmigiani S, vom Saal FS. Prenatal exposure to endocrine disrupting chemicals: effects on behavioral development. Neurosci Biobehav Rev. 1999;23:1011-1027.
3. Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol. 2011;127:204-215.
4. Hong EJ, Park SH, Choi KC, Leung PC, Jeung EB. Identification of estrogen-regulated genes by microarray analysis of the uterus of immature rats exposed to endocrine disrupting chemicals. Reprod Biol Endocrinol. 2006;4:49.
5. Li Y, Luh CJ, Burns KA, et al. Endocrine-disrupting chemicals (EDCs): in vitro mechanism of estrogenic activation and differential effects on ER target genes. Environ Health Perspect. 2013;121: 459-466.
6. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the US population to bisphenolAand 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect. 2008;116:39-44.
7. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev. 2009;30:75-95.
8. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol (Elmsford, NY). 2007;24:139-177.
9. Grace PB, Taylor JI, Low YL, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev. 2004;13:698-708.
10. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res. 2001;61:5045-5050.
11. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor _. Endocrinology. 1998;139:4252-4263.
12. Gertz J, Reddy TE, Varley KE, Garabedian MJ, Myers RM. Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012;22:2153-2162.
13. Ricupito A, Del Pozzo G, Diano N, et al. Effect of bisphenol A with or without enzyme treatment on the proliferation and viability of MCF-7 cells. Environ Int. 2009;35:21-26.
14. Han D, Tachibana H, Yamada K. Inhibition of environmental estrogen-induced proliferation of human breast carcinoma MCF-7 cells by flavonoids. In Vitro Cell Dev Biol Anim. 2001;37:275-282.
15. Chlebowski RT. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009;360:573.
16. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med. 2001;344(4):276-278.
17. Clarke SD, Clarke IJ, Rao A, Evans RG, Henry BA. Differential effects of acute and chronic estrogen treatment on thermogenic and metabolic pathways in ovariectomized sheep. Endocrinology. 2013;154:184-192.
18. Liu F, Benashski SE, Xu Y, Siegel M, McCullough LD. Effects of chronic and acute oestrogen replacement therapy in aged animals after experimental stroke. J Neuroendocrinol. 2012;24:319-330.
19. Kuba T, Hunter D, Zhou L, Jenab S, Quinones-Jenab V. Acute and chronic estradiol replacements differentially alter corticosterone and COX-mediated responses to an inflammatory stimulus in female rats. Ethnic Dis 2010;20(1): 50-54.
20. Wang J, Jenkins S, Lamartiniere CA. Cell proliferation and apoptosis in rat mammary glands following combinational exposure to bisphenol A and genistein. BMC Cancer. 2014;14:379.
21. Burd CJ, Ward JM, Crusselle-Davis VJ, et al. Analysis of chromatin dynamics during glucocorticoid receptor activation. Mol Cell Biol. 2012;32:1805-1817.
22. Burch JB, Weintraub H. Temporal order of chromatin structural changes associated with activation of the major chicken vitellogenin gene. Cell. 1983;33:65-76.
23. Hon G, Wang W, Ren B. Discovery and annotation of functional chromatin signatures in the human genome. PLoS Comput Biol. 2009;5(11):e1000566.
24. Burd CJ, Archer TK. Chromatin architecture defines the glucocorticoid response. Mol Cell Endocrinol. 2013;380:25-31.
25. He HH, Meyer CA, Chen MW, Jordan VC, Brown M, Liu XS. Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res. 2012;22:1015-1025.
26. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology. 1993;132:2279-2286.
27. Maggiolini M, Bonofiglio D, Marsico S, et al. Estrogen receptor α mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol. 2001;60:595-602.
28. Korach KS, Sarver P, Chae K, McLachlan JA, McKinney JD. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes. Mol Pharmacol. 1988;33:120-126.
29. Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonyl-phenol: An estrogenic xenobiotic released from “modified” polystyrene. Environ Health Perspectives. 1991;92:167-173.
30. Liu C, Duan W, Li R, et al. Exposure to bisphenol A disrupts meiotic progression during spermatogenesis in adult rats through estrogen-like activity. Cell Death Dis. 2013;4:e676.
31. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S. Differential response of estrogen receptor α and estrogen receptor _ to partial estrogen agonists/antagonists. Mol Pharmacol. 1998;54:105-112.
32. vom Saal FS, Akingbemi BT, Belcher SM, et al. Chapel Hill Bisphenol A Expert Panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol (Elmsford, NY). 2007; 24:131-138.
33. Henley DV, Korach KS. Physiological effects and mechanisms of action of endocrine disrupting chemicals that alter estrogen signaling. Hormones. 2010;9:191-205.
34. Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett. 2008;269:226-242.
35. Rezg R, El-Fazaa S, Gharbi N, Mornagui B. Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. Environ Int. 2014;64:83-90.
36. Kato S, Yokoyama A, Fujiki R. Nuclear receptor coregulators merge transcriptional coregulation with epigenetic regulation. Trends Biochem Sci. 2011;36:272-281.
37. Doherty LF, Bromer JG, Zhou Y, Aldad TS, Taylor HS. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Horm Cancer. 2010; 1:146-155.